Evaluation of a novel tumor vaccine in dogs with hemangiosarcoma.

@article{Uren2007EvaluationOA,
  title={Evaluation of a novel tumor vaccine in dogs with hemangiosarcoma.},
  author={Lance U'ren and Barbara J Biller and Robyn E Elmslie and Douglas H. Thamm and Steven Dow},
  journal={Journal of veterinary internal medicine},
  year={2007},
  volume={21 1},
  pages={113-20}
}
BACKGROUND Hemangiosarcoma (HSA) is a highly metastatic and often rapidly fatal tumor of dogs. At present, adjuvant chemotherapy is the only proven effective treatment for dogs with HSA, though the benefits from chemotherapy are modest. Administration of immunotherapy together with chemotherapy has also been reported to improve survival in dogs with HSA. Therefore, we evaluated safety and immunologic responses to a novel tumor vaccine administered together with doxorubicin chemotherapy in dogs… CONTINUE READING